Search Results - K. N. Grigoreva

Refine Results
  1. 1

    Georgios Nikolaou Papanikolaou by А. D. Kondrashova, K. N. Grigoreva

    Published 2024-03-01

    Over entire life, Georgios Nikolaou Papanikolaou studied cytology of the female reproductive system. Owing to Dr. Papanikolaou’sefforts, the Pap test was created, which is relevant in diagnostics of early stage cervical cancer even today.

    Get full text
    Article
  2. 2

    To a question about the necessity and indications for genetic screening in obstetric and gynecological practice by K. N. Grigoreva, E. G. Demianovskaya, V. O. Bitsadze, J. Kh. Khizroeva, N. R. Gashimova, E. V. Slukhanchuk, I. S. Kalashnikova

    Published 2023-01-01

    Here, we discuss an importance and necessity of genetic research in work of an obstetrician-gynecologist of primary health care upon providing medical care. Infertility, habitual miscarriage, the birth of children with congenital malformations greatly affects psycho-emotional state of both women and...

    Full description

    Get full text
    Article
  3. 3

    100 years of Moschcowitz disease and thrombotic microangiopathy research: a look into the past and prospects by A. Yu. Shatilina, A. B. Hajiyeva, L. M. Valikhanova, A. A. Meshcheryakov, N. R. Gashimova, K. N. Grigoreva, A. V. Vorobev

    Published 2024-09-01

    In this article we review the history of the thrombotic microangiopathy (TMA) study over the past 100 years. Important events and discoveries made by scientists across the globe are described, which profoundly contributed to understanding TMA etiology, pathogenesis and treatment. The prospects for c...

    Full description

    Get full text
    Article
  4. 4

    Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome by A. D. Makatsariya, K. N. Grigoreva, M. A. Mingalimov, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, I. Elalamy, A. S. Shkoda, V. B. Nemirovskiy, D. V. Blinov, D. V. Mitryuk

    Published 2020-07-01

    COVID-19 is an infectious disease caused by the beta-coronavirus SARS-CoV-2 that in 2020 has spread worldwide. In most severe patients, the clinical picture begins with respiratory failure further deteriorating up to multiple organ failure. Development of coagulopathy is the most adverse prognostic....

    Full description

    Get full text
    Article
  5. 5

    Preeclampsia and venous thromboembolism by K. N. Grigoreva, V. O. Bitsadze, J. Kh. Khizroeva, E. V. Slukhanchuk, M. V. Tretyakova, N. A. Makatsariya, J.-Ch. Gris, G. C. Di Renzo, V. I. Tsibizova, D. V. Blinov, A. D. Makatsariya

    Published 2022-07-01

    Preeclampsia (PE) is a multisystemic disease that has been recorded as a complication in up to 15 % of pregnancies being lead cause of maternal mortality worldwide. Despite that PE pathophysiology has not been fully elucidated, it is currently believed that the endothelial dysfunction and pro-inflam...

    Full description

    Get full text
    Article
  6. 6

    Recurrent thrombosis in malignant neoplasms: clinical significance of long-term anticoagulant prophylaxis by A. V. Vorobеv, A. G. Solopova, N. V. Lomakin, V. O. Bitsadze, M. V. Kim, K. N. Grigoreva, K. V. Gadatskaia, V. N. Galkin, D. O. Utkin, I. Elalamy, A. D. Makatsariya

    Published 2025-05-01

    Aim: to stratify the risk of thrombosis and assess frequency of recurrent venous thromboembolism (VTE) and bleeding during long-term anticoagulant therapy (АСТ) in patients with stage III–IV ovarian cancer (ОС).Materials and Methods. A prospective interventional comparative non-randomized study was...

    Full description

    Get full text
    Article
  7. 7

    Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women by N. R. Gashimova, K. N. Grigoreva, V. O. Bitsadze, L. L. Pankratyeva, J. Kh. Khizroeva, M. V. Tretyakova, Ya. M. Shammut, E. Iu. Iupatov, V. I. Tsibizova, J.-K. Gris, D. V. Blinov, A. D. Makatsariya

    Published 2023-03-01

    Introduction. Coronavirus infection is associated with severe endotheliopathy, thromboinflammation and immunothrombosis leading to excessive release of von Willebrand factor (vWF) multimers from Weibel–Palade bodies, which can affect activity of ADAMTS-13 metalloproteinase (a disintegrin and metallo...

    Full description

    Get full text
    Article
  8. 8

    Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice by K. N. Grigoreva, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, D. A. Ponomarev, K. Yu. Tsvetnova, D. A. Doronicheva, A. R. Mamaeva, K. V. Mekhedova, G. Rizzo, J.-C. Gris, I. Elalamy, A. D. Makatsariya

    Published 2021-03-01

    ADAMTS-13 is a crucial metalloproteinase involved in liberating fragments of von Willebrand factor (vWF) into the plasma as well as regulating its activity by cleaving "ultra-large" multimers into smaller and less active counterparts. Many pathological conditions, including those emerged d...

    Full description

    Get full text
    Article
  9. 9

    Prognostic value of von Willebrand factor in clinical practice by K. N. Grigoreva, V. O. Bitsadze, J. Kh. Khizroeva, V. I. Tsibizova, M. V. Tretyakova, D. V. Blinov, L. L. Pankratyeva, N. R. Gashimova, F. E. Yakubova, A. S. Antonova, J.-C. Gris, I. Elalamy, A. D. Makatsariya

    Published 2022-11-01

    The von Willebrand factor (vWF) is a multimeric plasma glycoprotein, which quantification has important prognostic value. The current literature review demonstrates a relationship between the disease severity and vWF level. For example, von Willebrand disease is characterized by a quantitative/quali...

    Full description

    Get full text
    Article
  10. 10

    Dysregulated platelet function in COVID-19 patients by N. R. Gashimova, V. O. Bitsadze, L. L. Pankratyeva, J. Kh. Khizroeva, E. V. Slukhanchuk, K. N. Grigoreva, V. I. Tsibizova, J.-C. Gris, I. Elalamy, C. Ay, D. V. Blinov, V. N. Serov, A. D. Makatsariya

    Published 2023-01-01

    More than two year-experience in monitoring patients with severe novel coronavirus disease revealed an increased risk of macroand microcirculatory thrombosis, clinically manifested by heart attack, stroke, thromboses of rare localizations (thrombosis of the hepatic veins, mesenteric veins, cerebral...

    Full description

    Get full text
    Article
  11. 11

    Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins by V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, N. V. Pyatigorskaya, S. V. Akinshina, N. A. Makatsariya, K. E. Gotsiridze, N. N. Babaeva, K. N. Grigoreva, A. S. Shkoda, I. Elalamy, J.-C. Gris, S. Shulman

    Published 2021-07-01

    Our knowledge regarding chemical structure and properties of heparin and its derivatives, including biological properties in blood plasma, on the cell surface and while interacting with receptors, has been progressively growing. New insights are followed by the expansion of therapeutic opportunities...

    Full description

    Get full text
    Article
  12. 12

    Functioning of the ADAMTS-13/vWF axis and its clinical significance by K. N. Grigoreva, N. R. Gashimova, V. O. Bitsadze, L. L. Pankratyeva, J. Kh. Khizroeva, M. V. Tretyakova, J.-C. Gris, A. E. Malikova, D. V. Blinov, V. I. Tsibizova, N. D. Degtyareva, S. V. Martirosyan, A. D. Makatsariya

    Published 2023-03-01

    Advances in biology have allowed us to substantially deepen our knowledge about hemostasis functioning both in health and disease. ADAMTS-13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13) and von Willebrand factor (vWF) are components of the hemostasis system, whic...

    Full description

    Get full text
    Article
  13. 13

    Intrauterine activation of the fetal immune system in response to maternal COVID-19 by N. R. Gashimova, L. L. Pankratyeva, V. O. Bitsadze, J. Kh. Khizroeva, N. A. Makatsariya, M. V. Tretyakova, A. S. Shkoda, K. N. Grigoreva, V. I. Tsibizova, J.-C. Gris, F. E. Yakubova, D. V. Blinov, A. D. Makatsariya

    Published 2023-05-01

    Introduction. During pregnancy COVID-19 poses a serious threat to both maternal health and health of paired unborn child. Pregnant women have a high probability of complications due to respiratory viral infections followed by developing critical conditions caused by physiologically altered immune an...

    Full description

    Get full text
    Article
  14. 14

    Septic shock by V. O. Bitsadze, T. A. Sukontseva, S. V. Akinshina, Ya. Yu. Sulina, J. Kh. Khizroeva, M. V. Tretyakova, Kh. G. Sultangadzhieva, J. Yu. Ungiadze, N. V. Samburova, K. N. Grigoreva, V. I. Tsibizova, A. S. Shkoda, D. V. Blinov, A. D. Makatsariya

    Published 2020-09-01

    The problem of sepsis and septic shock has recently become more and more actual. In obstetrics and gynaecology, the number of cases of sepsis has more than doubled over the past 10 years. The review examines the clinical forms of septic conditions, risk factors, pathogenesis of sepsis and septic sho...

    Full description

    Get full text
    Article
  15. 15

    How to reduce a risk of venous thromboembolism while taking combined oral contraceptives by V. O. Bitsadze, J. Kh. Khizroeva, A. G. Solopova, M. V. Kvaratskheliia, D. Yu. Zabolotnaya, Z. Xiaoxia, M. V. Tretyakova, V. I. Tsibizova, N. R. Gashimova, K. N. Grigoreva, M. A. Gileva, A. S. Shkoda, J.-Ch. Gris, A. D. Makatsariya

    Published 2023-07-01

    The review presents data on the evolution of combined oral contraceptives (COCs), related most frequent and dangerous side effects including venous thromboembolism (VTE). The issue of VTE upon administration of COCs is highlighted, and the risks of such complication in patients receiving hormonal co...

    Full description

    Get full text
    Article
  16. 16

    Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation by K. N. Grigoreva, N. R. Gashimova, V. O. Bitsadze, L. L. Pankratyeva, J. Kh. Khizroeva, M. V. Tretyakova, V. I. Tsibizova, N. D. Degtyareva, A. V. Mulenkova, J.-C. Gris, M. V. Kvaratskheliia, E. Grandone, F. E. Yakubova, D. V. Blinov, A. D. Makatsariya

    Published 2023-05-01

    Introduction. The pandemic of a novel coronavirus infection has demonstrated the importance of assessing the ADAMTS-13/vWF axis in patients with COVID-19, because a decline in this ratio mirrors disease severity. However very few data in the global literature on crosstalk and ADAMTS-13/vWF levels in...

    Full description

    Get full text
    Article
  17. 17

    Chemotherapy and hemostasis disorders by E. V. Slukhanchuk, V. O. Bitsadze, A. G. Solopova, J. Kh. Khizroeva, K. N. Grigoreva, N. R. Gashimova, N. A. Makatsariya, D. V. Blinov, V. N. Galkin, A. Yu. Shatilina, E. M. Lyadnova, N. A. Shulga, L. T. Toguzaeva, S. Morkos, J.-C. Gris, I. Elalamy, G. Gerotziafas, A. D. Makatsariya

    Published 2025-01-01

    Cancer patients are at risk of developing arterial and venous thrombosis during chemotherapy (CT) and after its cessation. A prothrombotic risk may arise via pathogenetic pathways such as activation of external and internal coagulation pathways, decreased anticoagulant levels, platelet activation, f...

    Full description

    Get full text
    Article
  18. 18

    The concept of thromboinflammation underlying thrombotic complications, tumor progression and metastasis in gynecological cancer patients by A. D. Makatsariya, E. V. Slukhanchuk, V. O. Bitsadze, A. G. Solopova, J. Kh. Khizroeva, L. A. Ashrafyan, V. N. Serov, A. Е. Voynovskiy, J. Yu. Ungiadze, A. V. Lazarchuk, M. V. Tretyakova, N. A. Makatsariya, P. V. Salnikova, N. R. Gashimova, K. N. Grigoreva, K. L. Zakashansky, I. Elalamy, J.-C. Gris

    Published 2024-09-01

    The results of recent studies show that tumor biology, coagulation activation, and inflammatory reactions profoundly contribute to the thrombosis pathogenesis in cancer as well as tumor progression, metastasis, and developing chemoresistance. Cancer is an independent predictor of thrombosis. During...

    Full description

    Get full text
    Article
  19. 19

    Venous and arterial thromboses in ART programs: epidemiology and preventive strategies by V. O. Bitsadze, J. Kh. Khizroeva, E. Grandone, R. I. Gabidullina, M. V. Tretyakova, N. A. Makatsariya, N. R. Gashimova, K. N. Grigoreva, A. V. Vorobev, A. V. Lazarchuk, M. M. Muravyova, A. G. Krendeleva, T. E. Polyakova, M. S. Zainulina, D. L. Kapanadze, F. E. Yagubova, J.-C. Gris, I. Elalamy, G. Gerotziafas, P. Van Dreden, A. D. Makatsariya

    Published 2025-07-01

    Here, we review the current data on the relationship between in vitro fertilization (IVF) procedures and thrombotic complications by focusing on epidemiological, pathophysiological and clinical aspects. Although being a rare IVF complication (incidence is about 0.2 %), thrombosis poses a serious thr...

    Full description

    Get full text
    Article
  20. 20

    Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT co... by A. D. Makatsariya, S. V. Akinshina, A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, N. A. Makatsariya, I. S. Kalashnikova, N. R. Gashimova, K. N. Grigoreva, I. A. Stepanov, I. M. Dikareva, A. Yu. Tatarintseva, A. V. Lazarchuk, A. R. Khisamieva, D. V. Blinov, P. Van Dreden, J.-Ch. Gris, I. Elalamy, G. Gerotziafas

    Published 2025-03-01

    Aim: to carry out a comparative analysis of the pathogenesis, clinical manifestations, diagnostic criteria as well as therapeutic strategies of vaccine-induced thrombotic thrombocytopenia (VITТ) and heparin-induced thrombocytopenia (HIT), two rare but potentially life-threatening conditions associat...

    Full description

    Get full text
    Article